Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Margo De Velder

Publications & Research Data

Awards & Distinctions

4 Results

2026

Cationic mRNA lipid nanoparticles for ex vivo NanoCAR‐T cell engineering

Laure HarinckStijn De MunterMargo De VelderJoline IngelsDominika BerdeckaIne LentackerWinnok H. De VosBart VandekerckhoveKevin BraeckmansKoen Raemdonck

A1 Journal Article in ADVANCED SCIENCE

2025

Gentle and efficient engineering of primary human NK cells by photoporation with polydopamine nanosensitizers

Charlotte HinnekensJana RamonM. BirbenW.T.V. GermeraadA. HarizajMargo De VelderStefaan De SmedtBart VandekerckhoveKevin BraeckmansJuan Fraire

A1 Journal Article in JOURNAL OF CONTROLLED RELEASE

Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs

Sofie MeulewaeterMargo De VelderDiethard ReckelbusKevin MwangiThomas EhouarneIlke AernoutYanou EngelenFëllanza HalimiIsis Van herteryckLobke De Bels et al.

A1 Journal Article in MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT

2024

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

Sofie MeulewaeterIlke AernoutJoke DeprezYanou EngelenMargo De VelderLorenzo FranceschiniKarine BreckpotSerge Van CalenberghCaroline AsselmanKatie Boucher et al.

A1 Journal Article in JOURNAL OF CONTROLLED RELEASE